TGFB1 and cancer: The malignant conversion of TGF‐β is achieved by stimulating EMT and cancer stemness within cancer cells, inducing an immunosuppressive environment to minimize the elimination of cancer cells, and exacerbating the production of itself from cancer as well as other stromal cells (Barcellos‐Hoff and Akhurst, 2009).